UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 1, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40357 MARVELL TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

证券研究报告 迈威尔科技 (MRVL US) 指引符合预期，关注大客户 ASIC 项 目合作进展 | 华泰研究 | | | 年报点评 | | --- | --- | --- | --- | | 2025 年 | 3 月 | 11 日│美国 | 半导体 | Marvell 于 3/6 发布 4QFY25 财报，业绩发布后首个交易日公司股价下跌 19.8%，我们认为主因：1）业绩/下季度营收指引仅符合市场预期，公司 预计下季度数据中心收入环增中高个位数，增速有所放缓，不及市场乐观 预期；2）市场担忧其与大客户下一代项目合作的持续性。维持"增持"。 1QFY26 营收指引符合预期，预计数据中心业务环增中高个位数 公司 4QFY25 实现营收 18.17 亿美元，Non-GAAP 净利润 5.3 亿美元，符 合彭博一致预期的 18.0/5.2 亿美元，其中，数据中心业务受益：1）ASIC 项目进一步放量，2）800G 光模块 DSP 等订单保持旺盛，营收再创历史 新高达 13.66 亿美元（yoy+78%，qoq+24%）；运营商基础设施业务随下 游需求回暖环比有所改善。公司指引 1QFY26 营收 18.75 亿（ ...

Core Viewpoint - The article emphasizes that a HODL strategy may not yield significant alpha or maintain a high Sharpe ratio over the long term, suggesting that active management is essential for maximizing returns and minimizing opportunity costs [1]. Group 1: Investment Strategy - The company advocates for active management in investment strategies to achieve high positive returns, indicating that merely seeking high returns does not equate to generating high alpha [1]. Group 2: Analyst Background - The analyst has a strong educational background with a degree in Business Economics from UCLA and a Master of Accounting from UMich Ross School of Business, indicating a solid foundation in financial analysis [1]. - The analyst is currently a senior analyst at a multi-strategy hedge fund, which suggests experience in diverse investment strategies [1].

Chip stocks have been very valuable to investors' portfolios, but many have continued to decline in recent months following the announcement of China-based DeepSeek’s advancement in artificial intelligence at a more affordable cost. The selloff has been compounded by ongoing tariff concerns, with stocks like Marvell Technology (MRVL)  which will be featured in this article, having generated massive gains only to slump in a gut-wrenching fluctuation.  However, AI chip leaders like Nvidia (NVDA) and AMD (AMD) ...

Core Viewpoint - Marvell Technology, a prominent player in the AI sector, has experienced a significant decline in stock value in 2025 despite strong performance metrics and positive earnings reports [1][3][10] Financial Performance - In fiscal Q4 2025, Marvell's sales and adjusted EPS exceeded expectations by 1% to 2% [3] - The company forecasts a 61% revenue growth for the next quarter compared to the same period last year, with adjusted EPS expected to rise by 154% [4] - Marvell's data center business saw impressive growth of 88% in 2024, although other end markets faced declines [4][7] Market Context - The technology sector, including Marvell, is currently facing a generalized sense of fear, with the Technology Select Sector SPDR Fund down 14% from its recent high [2] - Historical performance indicates that Marvell's stock is highly sensitive to market downturns, having dropped 58% during the last significant tech market decline in 2022 [6] Business Composition - In 2022, Marvell's revenue was approximately $5.9 billion, with 41% coming from data centers; by 2024, data centers accounted for over 72% of revenue, indicating a significant shift in business focus [7][8] Industry Outlook - Major tech hyperscalers are projected to invest over $300 billion in AI infrastructure in 2025, which is crucial for Marvell's business [9] - Despite potential recession fears, the demand for AI-related services may remain robust, as large tech companies are unlikely to retract their investment commitments [9][10] Analyst Sentiment - Marvell Technology currently holds a Buy rating among analysts, with a 12-month stock price forecast of $120.44, indicating an 82.06% upside potential [7]

Shares of Marvell Technologies (MRVL -7.30%) were plunging following its fiscal 2025 fourth-quarter earnings report, despite the company seeing strong data center and artificial intelligence (AI) revenue growth. The stock is now down more than 40% year to date.Let's take a closer look at the chipmaker's latest report and guidance to see if this sell-off is a good opportunity to buy the stock.Strong data center revenueMarvell is tied to the data center market as it provides networking chips, connectivity sol ...

Company Overview - Marvel Biosciences Corp. is a Calgary-based pre-clinical stage pharmaceutical development biotechnology company that employs a "drug redevelopment" approach to drug development [4] - The company focuses on creating new, patent-protected derivatives of off-patent drugs, optimizing them for additional indications, which significantly reduces time, cost, and risk compared to traditional biotech models [4] - Marvel's lead compound targets the A2a adenosine receptor, with potential applications in neurological diseases such as Alzheimer's Disease, as well as cognitive and behavioral health conditions like Depression and Anxiety [4] - The company is also exploring its lead compound's potential in treating neurodevelopmental disorders, including Autism, Rett Syndrome, and Fragile X Syndrome [4] Industry Engagement - Marvel Biosciences Corp. will attend and present at the Bloom Burton & Co. Healthcare Investor Conference on May 5 and 6, 2025, at the Metro Toronto Convention Centre [1][2] - The conference aims to connect U.S., Canadian, and international investors with the latest developments in the Canadian healthcare sector [2] - Marvel's CEO Rod Matheson and CSO Mark Williams will participate in a group presentation and one-on-one meetings with investors at the conference [2][3]

Marvell Technology, Inc. (NASDAQ: MRVL ) stock has crashed in the past month as it plunged by over 40%. I believe this is an overreaction. In the below analysis, the technicals are determined to be heavily bearish, but that is noI'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honour Society.My motto is John Pierpont Morgan's phras ...

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure: I/we have a beneficial long position in the shares of NVDA, AVGO, MRVL either through stock ownership, options, or other derivatives. I wrote this ...

Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!Marvell Technology, Inc. (NASDAQ: MRVL ) is a $60-billion market cap semiconductor company that specializes in the design, development, and marketing of a wide range of integrated circuits and solutions for data infrastructure building. So their products are basical ...